公司

Biohaven

关注打开结构图就此提问研究这家公司

简介

总部: US

Biohaven 的结构

Biohaven

公司

7 个关联

上游供应与依赖3 / 5

同行竞争与合作

自有产品与技术

关系出现时间2026待整理节点

Biohaven公司 · 7 个关联

第 1 层

上游供应与依赖3

同行竞争与合作2

自有产品与技术2

关系

箭头表示关系方向，可按业务类别筛选。

Biohaven签署协议 →Ono Pharma
公司 · Ono Pharma证据 1
事实90%
查看证据
- 公司披露PR Newswire news releases2026-10-08 16:00
  Under the terms of the agreement, Ono will obtain an exclusive license to develop and commercialize BHV-1300, BHV-1310, and BHV-1320
  查看来源
BHV-1310属于 →Biohaven
产品 · BHV-1310证据 1
事实90%
查看证据
- 公司披露PR Newswire news releases2026-10-08 16:00
  extending the breadth and durability of Biohaven's MoDE IgG degrader portfolio
  查看来源
BHV-1320属于 →Biohaven
产品 · BHV-1320证据 1
事实90%
查看证据
- 公司披露PR Newswire news releases2026-10-08 16:00
  extending the breadth and durability of Biohaven's MoDE IgG degrader portfolio
  查看来源
Biohaven使用 →MoDE
技术 · MoDE证据 1
事实90%
查看证据
- 公司披露PR Newswire news releases2026-10-08 16:00
  Biohaven's MoDE platform is the first clinically validated technology enabling the targeted degradation of disease-causing proteins in the extracellular space.
  查看来源
Biohaven使用 →TRAP
技术 · TRAP证据 1
事实90%
查看证据
- 公司披露PR Newswire news releases2026-10-08 16:00
  Biohaven's next-generation TRAP (Targeted Removal of Aberrant Protein) degraders extend the platform with highly selective molecules, each engineered to remove a single specific disease-causing protein.
  查看来源
Biohaven经营于 →immunology
产业 · immunology证据 1
事实90%
查看证据
- 公司披露PR Newswire news releases2026-10-08 16:00
  Biohaven Ltd. (NYSE: BHVN) is a biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments across immunology, neuroscience, and oncology.
  查看来源
Biohaven经营于 →neuroscience
产业 · neuroscience证据 1
事实90%
查看证据
- 公司披露PR Newswire news releases2026-10-08 16:00
  Biohaven Ltd. (NYSE: BHVN) is a biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments across immunology, neuroscience, and oncology.
  查看来源
Biohaven经营于 →oncology
产业 · oncology证据 1
事实90%
查看证据
- 公司披露PR Newswire news releases2026-10-08 16:00
  Biohaven Ltd. (NYSE: BHVN) is a biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments across immunology, neuroscience, and oncology.
  查看来源

显示第 1 至 8 条，共 13 条

结论

结合来源阅读结论，展开条目查看证据。

事实证据 1

经营于neuroscience

Biohaven Ltd. (NYSE: BHVN) is a biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments across immunology, neuroscience, and oncology.